Stay updated on APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Sign up to get notified when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2, while the study page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:43:17.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:48:06.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to indicate a new version of the study record. A broad set of study metadata items, including FDA-regulated status, IPD sharing, and location/investigator terms, were removed from the page.
    Difference
    18%
    Check dated 2026-09-21T22:45:34.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Footer shows the updated revision tag 'Revision: v3.6.6', replacing the previous 'v3.6.5'. This indicates a small site update rather than changes to the study content or data.
    Difference
    0.0%
    Check dated 2026-08-31T17:05:59.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page's revision label was updated to Revision: v3.6.5, indicating the study record has been updated.
    Difference
    0.0%
    Check dated 2026-08-10T14:53:17.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, reflecting a backend update. This change does not alter the displayed study details.
    Difference
    0.0%
    Check dated 2026-07-27T06:19:28.000Z thumbnail image

Stay in the know with updates to APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.